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PURPOSE. To develop a mouse model of limbal stem cell deficiency (LSCD) by topical
administration of benzalkonium chloride (BAC).
METHODS. BAC solutions (0%–0.5%) were applied to the mouse ocular surface for 4 weeks.
Corneal neovascularization, inflammation, and epithelial status were observed under slit-lamp
microscope. The eyeball and ocular surface tissues were collected at 4 and 12 weeks and
labeled with a series of antibodies. Limbal structure was evaluated by light and transmission
electron microscopy (TEM). Corneal impression cytology was performed at 12 weeks, and
specimens were labeled with periodic acid Schiff (PAS) reagents.
RESULTS. BAC (0.5%) four times per day for 28 days successfully induced the typical
manifestations of LSCD, including corneal neovascularization, severe inflammation in the
stroma, and diffuse epithelial defect (P < 0.001). Conjunctival epithelium markers K19 and
K13 were positive on the corneal surface. Expression of the putative limbal stem cell markers
P63 and ABCG2 was abolished in the limbal epithelium. b-catenin was negative in the basal
layer. TEM revealed the irregular basement membrane and the loss of stem cell–specific
ultrastructure in the limbal basal epithelium. In the 0.5% BAC group, goblet cells could not be
observed on day 28 but emerged after the cessation of BAC, and remained over the cornea
after 8 weeks. K13-positive cells were still present over the cornea with the loss of K12.
CONCLUSIONS. Topical administration of BAC at high concentration and frequency in mouse
induces ocular surface changes resembling those of LSCD in humans, representing a novel
model of LSCD.
Keywords: limbal stem cell deficiency, benzalkonium chloride, inflammation, squamous
metaplasia, goblet cell
In 1971, the pericorneal palisades were first proposed torepresent the source for renewal of corneal epithelial cells.1
Located in the basal layer of the palisades of Vogt, limbal stem
cells (LSCs) are interspersed with early transient amplifying
cells (TACs), which migrate toward the surface epithelium and
the center of cornea and terminally differentiate into corneal
epithelium.2 Limbal stem cells were recognized to possess the
critical ability to regenerate corneal epithelium, offering great
therapeutic potential for re-epithelization.3 Multiple diseases
that damage LSCs, their surrounding microenvironment
(niche), or both, can lead to a pathological state known as
limbal stem cell deficiency (LSCD), signs of which include
corneal conjunctivalization, neovascularization, epithelium
defect, and chronic ocular surface inflammation. Corneal
conjunctivalization is recognized as the definitive diagnosis of
LSCD, and can be determined by identification of goblet cells or
conjunctival epithelium on the surface of the cornea.3
Congenital limbal insufficiency includes aniridia, sclerocor-
nea, and endocrinologic disturbances,4 while acquired LSCD
can arise from limbal injuries,5 ocular surface immune disorders
like Stevens Johnson syndrome,6 long-term contact lens
wearing,7 and overexposure to detrimental substances,8–11 A
large variety of therapies, such as amniotic membrane
transplantation, keratolimbal allograft, and transplantation of
ex vivo expanded limbal epithelial cells, have been developed
to treat LSCD and show inspiring clinical outcomes in
patients.12 However, the existing data are still limited by lack
of understanding of the mechanisms involved in the occurrence
of LSC failure. Until now, only one model of congenital LSCD
can be found in the spontaneously vascularized corneas of
corn1 and Pax6þ/ mice with conjunctival invasion,13 and
heterozygosity for Pax6 deficiency (Pax6þ/) results in aniridia.
Acute limbal destruction, as with severe chemical burns14 and
surgical removal of limbal tissues,5 has been used for the
induction of acquired LSCD in animals. However, the under-
standing of progressively developed LSCD is still limited by lack
of animal models resulting from chronic and long-term stress
over the ocular surface.
Benzalkonium chloride (BAC) is the most commonly used
preservative in ophthalmic solutions. Cumulative evidence
indicates that long-term use of preservative-containing topical
drugs has been recognized as a potential risk for many ocular
surface disorders15 due to the cellular toxicity. Certain doses of
preservatives contribute to damage of the corneal epithelium,
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endothelium and innervations, and the conjunctiva, as well as
other ocular tissues.16–19 In many patients, preservatives can be
the major cause of or aggravating factor for ocular surface
disorders, especially in those with dry eye and glaucoma, for
example. Pauly et al.20 systematically investigated the dose-
dependent toxicity of BAC to the ocular surface in Lewis rats after
long-term administration, with the observation of corneal
neovascularization, inflammation, and epithelium erosion. How-
ever, whether BAC was related to corneal conjunctivalization was
not mentioned, and the status of limbal epithelium remained
unclear. This present study was therefore conducted to evaluate
the toxicity of BAC on the ocular surface of the normal BALB/c
mouse and to develop a LSCD model with topical medication of
BAC, aiming to provide a better platform for future investigations.
MATERIALS AND METHODS
Animals and Administration of Benzalkonium
Chloride
Forty male BALB/c mice (18–20 g; purchased from Shanghai
Laboratory Animal Center [SLAC], Shanghai, China) were used
for this study, all of which were free of clinically observable
ocular surface diseases. The mice were maintained in a standard
environment throughout the study as follows: room tempera-
ture 258C 6 18C, relative humidity 60% 6 10%, and alternating
12-hour light–dark cycles (8 AM–8 PM). All procedures were
performed in accordance with the ARVO Statement for the Use
of Animals in Ophthalmic and Vision Research.
The mice were randomly assigned to four groups of 10 mice
each. For 28 days, each group received topical administration of
PBS as the control and BAC solution (0.1%, 0.25%, 0.5%,
respectively) at the right eye four times daily (9 AM, 1 PM, 5 PM,
9 PM). The BAC was dissolved in PBS.
Experimental Procedure
At each time point (on days 0, 1, 3, 7, 11, 15, 20, and 28),
clinical ocular surface alterations were evaluated. Criteria for
the diagnosis of LSCD included persistent corneal new vessels,
inflammation in the stroma, and corneal epithelial damage,
according to the methods described below.
The best concentration of BAC for the induction of LSCD
was determined based on the data (see Results). Six global
FIGURE 1. Clinical alterations of the ocular surface with BAC treatment. Corneal new vessels induced by BAC (0.5% concentration) emerged on day
7 and peaked on day 20 (A). Corneal inflammation index and fluorescein sodium staining score increased rapidly after BAC treatment, progressively
reached their peaks around day 11, earlier than corneal new vessels, and remained at a high level (D, G). Lower concentrations of BAC (0.1% and
0.25%) caused mild corneal new vessels, moderate inflammation in the stroma, and epithelium damage. Eyes in the PBS-treated group showed no
new vessels (B), no obvious corneal edema in the stroma (E), and no positive fluorescein sodium staining in the epithelium (H). In the 0.5% BAC-
treated group, dense new vessels (C), severe edema in the stroma (F), and diffuse positive fluorescein staining (I) were observed in the cornea.
Statistically significant at *P ¼ 0.001 and **P ¼ 0.000 compared to each of the other groups at the same time point.
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specimens in each group were dissected on day 28 for
histological analysis by light microscopy, immunostaining,
and transmission electron microscopy (TEM) as described
below. After 28 days, the other four mice in each group
stopped receiving BAC instillation and were kept alive for
corneal impression cytology and periodic acid Schiff (PAS)
staining. After 8-week cessation of BAC treatment, the four
mice were evaluated by slit lamp and killed for PAS and
immunostaining.
Measurement of New Vessels and Inflammation
Length of new vessels (NV) was examined and scored by a
single masked observer, who was an ophthalmologist, under
slit lamp (SLM-3; Kanghua Science & Technology Co., Ltd.,
Chongqing, China) at each time point as previously de-
scribed.20 The cornea was divided into four quadrants, which
were scored individually. The measurement of vessels was
quantified by the ratio of the largest length of vessels to the
corneal radius, briefly as follows: no vessels grown into clear
cornea, 0; one-quarter or less but not zero, 1; between one-
quarter and one-half, 2; between one-half and three-quarters, 3;
and more than three-quarters, 4. The final scores for NV were
calculated by summing the scores of the four quadrants (total,
16 points).
The severity of inflammatory response was analyzed under
slit lamp as previously described.21 The inflammatory index
was analyzed based on the following parameters: ciliary
hyperemia (absent, 0; present but less than 1 mm, 1; present
between 1 and 2 mm, 2; present and more than 2 mm, 3),
central corneal edema (absent, 0; present with visible iris
details, 1; present without visible iris details, 2; present
FIGURE 2. Representative images showing the inflammatory responses with BAC treatment on day 28. In BAC-treated eyes (B, D), fewer layers of
corneal epithelium were observed in the central cornea but more layers of epithelium in the limbal area when compared with the control (A, C).
Infiltration of inflammatory cells, as well as new vessels, was intensive in the stroma of BAC-treated eyes. CD4-positive cells also emerged in the
stroma of both the limbal and central cornea in 0.5% BAC-treated eyes (F, H). No CD4-positive cells were observed in the control eyes (E, G). Black
triangles, cavity of new vessels; black arrows, CD4-positive cells. Scale bar: 100 lm.
A Model of Limbal Stem Cell Deficiency IOVS j September 2013 j Vol. 54 j No. 9 j 6316
FIGURE 3. Representative images showing corneal conjunctivalization and partial loss of corneal phenotype on day 28. No differences in K19 or
K13 expression in the conjunctiva between control (A, G) and BAC-treated eyes (D, J). The expression of K19 and K13 was weaker in the basal
layers of the ocular surface of both groups. K19 and K13 staining was weak in the limbal epithelium of the control eyes (B, H), but much stronger
with 0.5% BAC treatment (E, K). Invasion of K19- and K13-positive epithelium could be observed in the central cornea of BAC-treated eyes (F, L) but
not in the control eyes (C, I). White arrows indicate the terminal ends of K19 (F) or K13 (L) invasion in the cornea. K10-positive cells were detected
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without visible pupil, 3), and peripheral corneal edema
(absent, 0; present with visible iris details, 1; present without
visible iris details, 2; present with no visible iris, 3). The final
inflammatory index result was obtained by summing the scores
of the different parameters divided by a factor of 9.
Evaluation of Fluorescein Staining
One microliter 1% liquid fluorescein sodium was dropped into
the conjunctival sac. Ninety seconds later, corneal epithelial
damage was graded with a cobalt blue filter under a slit-lamp
microscope. The cornea was divided into four quadrants,
which were scored respectively as previously described20 with
essential modification, briefly as follows: absent, 0; slightly
punctate staining less than 30 spots, 1; punctate staining more
than 30 spots, but not diffuse, 2; severe diffuse staining but no
positive plaque, 3; positive fluorescein plaque, 4. The scores of
each quadrant were added to arrive at a final grade (total, 16
points).
Corneal Impression Cytology
Corneal impression cytology (IC) was used to dynamically
monitor the emergence of goblet cells over the cornea. Corneal
IC specimens were collected every 2 days in the first week and
every 7 days in the following period until day 56 (8 weeks)
after the cessation of BAC instillation. Topical anesthesia by
0.4% oxybuprocaine was given to help immobilize the mice.
One 3-mm 3 3-mm circular disc of cellulose acetate membrane
filter paper (Advantec Toyo Roshi Kaisha, Tokyo, Japan) was
placed on the central corneal surface. After the filter paper was
pressed for 6 seconds with constant pressure, it was gently
lifted and fixed with 4% paraformaldehyde. The specimens
were stained with PAS reagents and hematoxylin.
Immunostaining
On day 28, the global tissues were embedded in optimal
cutting temperature (OCT) compound (Tissue-Tek; Miles, Inc.,
Elkhart, IN) and frozen at808C. Two global tissues of the mice
after cessation of BAC treatment for 8 weeks were also
embedded in OCT. OCT-embedded frozen sections (6 lm
thick) were cut with a cryotome (CM 1850UV; Leica Micro-
systems AG, Wetzlar, Germany) and stored at 808C. Global
sections were fixed in acetone at 48C for 10 minutes and
permeated with 0.2% Triton X-100 in PBS for 20 minutes.
For immunofluorescent labeling, after preincubation with
2% BSA in PBS for 60 minutes to block the nonspecific sites,
sections were incubated at 48C overnight with antibodies of
K19, K13, MUC5AC, b-catenin (1:50; Santa Cruz Biotechnology,
Santa Cruz, CA), and K10 (1:300; Abcam, Cambridge, UK).
After further incubation in Alexa Fluor 488– or Alexa Fluor
555–conjugated secondary antibodies (1:1000; Invitrogen,
Carlsbad, CA), sections were rinsed, counterstained with
4 0,6-diamidino-2-phenylindole (DAPI) or propidium iodide
(PI), mounted, and photographed using a confocal laser
in the superficial epithelium of the conjunctiva (P), the limbal area (Q), and the cornea (R) of BAC-treated eyes, but not in the control group (M–O).
In control eyes, K12 was expressed uniformly in all cell layers of the corneal epithelium (S). In BAC-treated eyes, K12 expression was negative in the
peripheral corneal surface but still positive around the central area (T). White triangles point at the limbus; white arrow indicates the border
between the lost and residual K12.
FIGURE 4. Representative images showing the absence of goblet cells in the corneal surface of control (A) and the BAC-treated eyes (C) on day 28.
The goblet cells were abundantly present in the conjunctival fornix of the control eyes (B) but almost disappeared after BAC treatment (D).
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scanning microscope (Fluoview FV1000; Olympus, Tokyo,
Japan) mentioned above.
For immunohistochemical staining, the activity of endog-
enous peroxidases was quenched with 0.6% hydrogen
peroxide for 30 minutes. After incubation with 2% BSA, the
antibodies of P63 (1:250; Abcam) and ABCG2 (1:25; Abcam)
were applied and incubated at 48C for 14 to 18 hours. After
rinsing with PBS, the sections were further incubated with
biotinylated anti-rabbit IgG (1:50) using Vectastain Elite ABC
kits (Vector Laboratories, Burlingame, CA) according to the
manufacturer’s protocol. The reaction product was then
developed with diaminobenzidine (DAB). Sections were
mounted and examined with a light microscope (Eclipse
50i; Nikon, Tokyo, Japan). P63 and ABCG2 were previously
reported to be predominantly expressed in the nucleus and
cytoplasm, respectively, of normal progenitor cells.22 As there
is only one layer of epithelial cells in the limbal zone of
normal mice, counterstaining with hematoxylin was not
performed to avoid possible interference during observation.
TEM and Light Microscopy
On day 28, two eyes randomly selected from each group were
enucleated and fixed for 2 hours in a mixture (pH 7.4) of 2.5%
glutaraldehyde and 4% paraformaldehyde in PBS. The limbal
tissues were cut to a size of 4 mm in length and 2 mm in width
FIGURE 5. Representative images showing the loss of putative stem cell markers with BAC treatment on day 28. In the control eyes, P63 was
strongly positive in the nucleus of limbal epithelium (A) and basal epithelium of the central cornea (B), while ABCG2 was expressed in the
cytoplasm of limbal epithelium (E) but weakly in the central cornea (F). With 0.5% BAC treatment for 28 days, both P63 (C, D) and ABCG2 (E–H)
were found to be absolutely negative in the limbal and central cornea. The dashed line (F–H) indicates the assumed basement membrane of
epithelium. Scale bar: 100 lm (A–H).
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without touching the epithelium and further embedded, sliced,
and stained. The ultrastructure of limbal epithelium was
examined and photographed with TEM (JEM2100HC; JEOL,
Tokyo, Japan).
Hematoxylin and eosin (HE) staining was performed in
cryosections fixed in acetone. Two specimens from mice after
cessation of BAC for 8 weeks were embedded in paraffin, cross
sectioned, and stained with PAS reagents and hematoxylin.
These sections were examined using the light microscope
(Nikon).
Statistical Analysis
Analysis of the significance of differences between groups was
performed using one-way ANOVA (SPSS 16.0 statistical
software; SPSS, Chicago, IL). P < 0.05 was considered
statistically significant.
RESULTS
Macroscopic and Slit-Lamp Examinations
The effects of BAC of different concentrations (0%, 0.1%,
0.25%, and 0.5%) were evaluated by neovascularization
scoring, inflammatory index, and fluorescein sodium staining
in the cornea. Based on the clinical diagnostic criteria, topical
administration of 0.5% BAC four times daily for 28 days was
considered the optimal procedure to induce putative LSCD in
BALB/c mice (P < 0.001, Fig. 1). Corneal new vessels induced
by BAC at 0.5% concentration emerged progressively after the
treatment (Fig. 1A), and corneal inflammatory index (Fig. 1D)
and fluorescein staining scores (Fig. 1G) indicated rapid and
persistent inflammatory response and epithelium damage.
Lower concentrations of BAC (0.1% and 0.25%) caused mild
corneal new vessels, moderate inflammation, and epithelium
FIGURE 6. Representative images of b-catenin. b-catenin was almost abolished in the basal epithelium of both the limbus ([C], white arrows) and
central cornea ([D], white arrows) with BAC treatment when compared with the control (A, B). Eight weeks after cessation of BAC, b-catenin was
abundantly expressed in all layers of the epithelium over the limbal and central cornea (E, F), where the putative outline of goblet cells could be
observed (white triangle).
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damage. Representative images of the eyes receiving PBS and
0.5% BAC are also shown in Figure 1.
BAC-Induced Inflammation in the Cornea
Histological analysis of sections revealed that the 0.5% BAC-
treated group had much more inflammatory cell infiltration in
the cornea and limbus than the PBS-treated group, which was
consistent with the results of corneal inflammatory index.
Stratified and irregular limbal epithelium was observed in the
BAC-treated eyes (Figs. 2A–D). Interestingly, CD4-positive cells
were intensively marked in the stroma of the limbal and central
cornea of 0.5% BAC-treated eyes on day 28 while negatively
labeled in the PBS-treated eyes, validating the immune
response with BAC administration (Figs. 2E–H).
Corneal Conjunctivalization
Fluorescent staining was performed to reveal alteration of
conjunctival epithelium markers K19 (Figs. 3A–F) and K13
(Figs. 3G–L) on the ocular surface. On day 28, no differences in
K19 or K13 expression in the conjunctiva were observed
between the control and the BAC-treated eyes. The K19 and
K13 staining in the limbal epithelium was weak in the control
but increased after 0.5% BAC treatment. The invasion of K19-
positive and K13-positive epithelium could be observed in the
FIGURE 7. Representative images showing the ultrastucture of limbal basal cells on day 28. A group of small, round-shaped cells could be observed
in the limbal basal epithelium of the control eyes. These cells resided on a regular and intact basement membrane without cytoplasmic processes,
and presented with rich heterochromatin and high nuclear to cytoplasmic ratio, while the nucleolus could be absent (A). In contrast, a cluster of
disordered, stratified, and larger epithelial cells were observed in the limbal basal epithelium of the 0.5% BAC-treated eyes, without obvious
heterochromatin or nucleolus of high density, resting on an irregular and wrinkled basement membrane (B). Scale bar: 2 lm.
FIGURE 8. Representative images showing the recovery of goblet cells after 8-week cessation of BAC treatment. The control cornea was transparent
(A), while diffuse and abundant corneal new vessels remained in the 0.5% BAC group after 8 weeks (E). PAS staining for the corneal IC specimens
revealed the presence of goblet cells over the cornea surface in the 0.5% BAC group (F), but absence in the control (B). Black triangles indicate
goblet cells in the corneal IC samples. PAS staining for paraffin sections also showed the emergence of goblet cells in the conjunctival fornix as well
as the corneal surface in the 0.5% BAC group (G, H). The superficial epithelium in the fornix was more stratified and morphologically abnormal in
the BAC group, implying the status of squamous metaplasia. Goblet cells in the control eyes were still localized mainly in the fornix (C, D). Scale
bar: 25 lm.
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central cornea of BAC-treated eyes but not in the control eyes.
In the 0.5% BAC group, K12 expression was lost in the
peripheral cornea but still positive around the central area
(Figs. 3S, 3T). These results revealed the presence of
conjunctival phenotype and the loss of corneal phenotype
over the corneal surface after 4 weeks of treatment with 0.5%
BAC.
Topical administration of 0.5% BAC for 28 days also induced
apparent cytoplasmic K10 expression in the superficial layer of
corneal, limbal, and conjunctival epithelium, indicating that
nonkeratinized epithelium of the ocular surface was partially
replaced by keratinized squamous epithelium (Figs. 3M–R).
However, MUC5AC-positive goblet cells were not detected
accordingly on the corneal surface of the 0.5% BAC-treated
eyes on day 28. The presence of goblet cells was confined to
the conjunctival fornix of the control eyes, but almost
undetectable in the BAC-treated eyes (Fig. 4).
Loss of Limbal Stem Cell Markers by BAC
The expression of putative LSC markers, P63 and ABCG2, was
analyzed by immunohistochemical staining (Fig. 5). In the
absence of BAC treatment, P63 was strongly positive in the
nucleus of limbal epithelium and basal epithelium of central
cornea; ABCG2 was positively expressed in the cytoplasm of
limbal epithelium and negatively in the central cornea. With
the 0.5% BAC treatment for 28 days, both P63 and ABCG2
were found to be absolutely negative in the limbal and central
cornea.
A LSC-associated marker, b-catenin, was also applied for
labeling (Fig. 6). In the control group, b-catenin was positive in
all layers of limbal and central epithelium. In contrast, its
expression was lost in the limbal basal epithelium after 0.5%
BAC treatment, but still positive in the superficial layer around
the limbus. In central cornea, b-catenin was apparently weaker
and even partly abolished in the basal and suprabasal
epithelium after BAC treatment. Interestingly, 8 weeks after
cessation of BAC, b-catenin expression was found in all layers
of limbal and central epithelium.
Ultrastructural Analysis
In normal mice, there was only one layer of epithelium at the
limbus. A group of small, round-shaped cells could be observed
in the limbal basal epithelium. These putative stem cells
resided on a regular and intact basement membrane without
cytoplasmic processes, and presented with rich heterochro-
matin and a high nuclear to cytoplasmic ratio, while the
nucleolus might be absent or not (Fig. 7A). In contrast, a
cluster of disordered, stratified, and larger epithelial cells was
observed in the limbal basal epithelium of the 0.5% BAC-treated
eyes, without obvious heterochromatin or nucleolus of high
density, resting on an irregular and wrinkled basement
membrane (Fig. 7B). The altered morphology of limbal
epithelial cells suggested that the characteristics of LSCs, such
as high proliferative potential, slow cell cycle, and low level of
differentiation, were probably abolished by long-term BAC
treatment.
FIGURE 9. Representative images showing persistent conjunctivalization and squamous metaplasia in the 0.5% BAC group after 8-week cessation of
BAC treatment. K13 expression remained uniformly in the corneal and conjunctival epithelium (A, B). No K12 expression could be observed on the
corneal surface (C, D). K10-positive cells were still present in both the conjunctiva and the cornea (E, F).
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Recovery of Goblet Cells and Persistent Corneal
Conjunctivalization After Cessation of BAC
After BAC treatment for 28 days, four mice in each group
stopped receiving BAC instillation and were kept alive. Corneal
impression cytology specimens were collected every 2 days in
the first week and every 7 days in the following period, and the
PAS assays were performed. Goblet cells were first observed in
the specimens collected on day 4 after the cessation of BAC
(data not shown). Goblet cells persistently existed on the
corneal surface even in the specimens collected 8 weeks after
the cessation of BAC (Fig. 8F). PAS staining for the paraffin
sections also showed the recovery of goblet cells in the
conjunctival fornix and corneal surface after 8 weeks of
cessation of BAC (Figs. 8G, 8H).
After 8 weeks of cessation of BAC, K13 was uniformly
expressed in the corneal and conjunctival epithelium. No K12
expression could be observed on the corneal surface. K10-
positive cells could still be observed in the conjunctiva and the
cornea. These data indicated that the corneal conjunctivaliza-
tion and the loss of the corneal phenotype were persistent at
least within 8 weeks after the cessation of BAC (Fig. 9).
DISCUSSION
Developing animal models that simulate LSCD would be
important for the clarification of mechanisms and evaluations
of therapeutic treatments. In this study, we introduced a mouse
model of LSCD induced by topical administration of a
commonly used preservative, BAC, with high frequency and
concentration. The observations by slit lamp revealed that the
manifestations of ocular disorders induced by topical treatment
with 0.5% BAC were consistent in principle with LSCD in
humans, notably including persistent corneal new vessels,
chronic inflammation in the stroma, epithelial defects, and
corneal conjunctivalization.
For decades, detection of goblet cells on the corneal surface
has been considered the gold standard for the diagnosis of
LSCD. However, the pathological condition of the ocular
surface in patients with LSCD is always complicated, especially
in those who suffer from severe dry eye or ocular surface
inflammation, such that the proliferation and differentiation of
vulnerable goblet cells is overwhelmingly interrupted. The
number of goblet cells was previously reported to be
apparently reduced or even abolished in animals23,24 and
patients25,26 with dry eye. Impression cytology can not always
remove all layers of epithelial cells, thus leading to difficulties
in assessing LSCD, especially in early stages. Immunolabeling of
histological sections was therefore performed to detect clues
on day 28. Cumulative evidence indicated that the identifica-
tion of conjunctiva-specific K19- or K13-positive epithelial cells
on the corneal surface would be a simple and practical method
to identify LSCD,9,27 as the invasion of conjunctiva remained
constant under various ocular surface stresses. Previous studies
revealed that K19-positive cells were present on the corneal
surface in a higher proportion (82%) than goblet cells (59%) in
patients with clinical definite LSCD,28 and that K13 might be
more specific than K19 in the diagnosis of LSCD.27 Our results
supported these studies with the observation of K19- and K13-
positive epithelial invasion into the corneal surface after BAC
treatment in BALB/c mice on day 28, in the absence of
MUC5AC-positive goblet cells. Based on these issues, we
considered that although the presence of goblet cells is needed
to confirm the diagnosis of LSCD, their absence does not
exclude the diagnosis. The depletion of goblet cells was not
permanent and could represent a temporary stage before the
alleviation of consistent BAC insults. This is supported by our
data showing that the goblet cells would recover over the
corneal surface after the cessation of BAC treatment (Fig. 8),
with the persistent presence of conjunctival K13 (Fig. 9B).
Although Majo et al.29 reported that the limbus was not the
only niche for corneal epithelial stem cells and that the murine
corneal epithelium contained potent stem cell-like cells, our
findings supported the pre-existing data indicating that the
corneal stem cells of the mouse reside in the limbal region,
with high expression of putative SC markers such as P63 and
ABCG2. As a P53 homologue, P63 is known to be essential for
epithelial development and stratification, and is consistently
expressed in the corneal basal epithelium with maximal levels
at the limbus in the mouse.30 ABCG2, a member of the
adenosine triphosphate–binding cassette (ABC) superfamily,
was correlated with the proliferative capacity of SCs and
appears to be the most reliable marker for the identification of
corneal epithelial SCs.31 The BAC-induced loss of P63 and
ABCG2 might indicate insufficiency for the proliferation and
differentiation of the LSCs, thus leading to poor re-epitheliza-
tion. b-catenin is not a specific marker for putative stem cells,
as there were no significant differences of expression density
between the cornea and limbus.32 However, b-catenin is a
pivotal component of the cadherin cell adhesion complex and
an essential molecule in the Wnt signaling pathway, a key
regulator of epithelial proliferation and differentiation. The
presence of Wnt signals allows LSCs to maintain their capacity
to undergo proliferation upon wounding.33 Based on our
findings, downregulation of b-catenin in the basal layer of
cornea and limbus could be considered a sign of impairment of
the capacity of epithelial stem cells by BAC. Interestingly, b-
catenin was abundantly expressed again in all layers of
epithelium over the limbal and central cornea at 8 weeks after
the cessation of BAC; but this result did not imply the recovery
of LSC function, since the limbal epithelium had converted to
conjunctiva.
The biological characteristics of BAC are mainly based on its
interaction with lipids, proteins (including G proteins) in the
biological membranes,34 and even genes. BAC has a wide
variety of cellular toxicity to the ocular tissues. In addition,
BAC is able to cause evaporation of the aqueous tear film as a
detergent for the lipid layer, thus leading to a dry eye
condition. Preservatives could also induce apoptosis at low
concentrations and necrosis at high concentrations17 in cell
cultures and animals, as well as in humans.20 These alterations
may stimulate production of a series of biological mediators in
the ocular surface and lead to subsequent proinflammatory and
inflammatory response and the creation of a vicious circle. Our
results indicated a BAC-induced severe inflammatory condition
in the ocular surface, including the upregulation of inflamma-
tory factors such as TNF-a (data not shown) and the infiltration
of CD4-positive T cells, reflecting chronic and immune
responses under longstanding BAC administration. One possi-
bility is that the LSCs were damaged directly by BAC instillation
in the BALB/c mouse. Given that the niche regulation for SCs
can be altered under severe chronic inflammation,35,36 thus
leading to insufficiency of SC functions, we speculated that
BAC might induce SC failure in different ways simultaneously,
including direct cytotoxicity and indirect damage to the niche
microenvironment surrounding the SCs through inflammatory
infiltration of CD4-positive T cells, for example. Nonetheless,
the detailed mechanisms need further investigation.
Squamous metaplasia is a hallmark of a variety of severe
ocular surface disorders including severe dry eye37 and LSCD,38
which is commonly seen under long-term deficiency of tear
film and chronic inflammatory infiltration in the ocular surface,
including the limbal epithelium.39 The loss of goblet cells
could be associated with the ocular surface squamous
metaplasia and long duration of BAC insult.8 After the cessation
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of BAC, goblet cells recovered in the conjunctival fornix as well
as the corneal surface. This indicated that LSCD and squamous
metaplasia could simultaneously exist (Fig. 8G), which is
consistent with previous studies regarding LSCD in chemical
burns,8 for example. Some researchers have pointed out that
the grade of squamous metaplasia correlates with the severity
of LSCD.38 In fact, the squamous metaplasia after BAC
treatment was well recorded in our previous study showing
that K10 could be observed on day 7 with twice-daily
instillation of BAC,40 when conjunctival K19 or K13 were still
negative over the cornea (data not shown). This indicated that
epithelial squamous metaplasia emerged much earlier than
corneal conjunctivalization in this model. In other words,
LSCD was not the initiating factor for squamous metaplasia,
although it might aggravate the condition of squamous
metaplasia. In addition, most of the K10 expression emerged
in the superficial layer of epithelium but was absent in the
basal layer more adjacent to the inflammatory cells in the
stroma, suggesting that the squamous metaplasia was probably
induced by long-term tear insufficiency. On the other hand, the
basal epithelium might also have certain mechanisms to escape
from inflammatory damage. These results were consistent with
the findings of Li et al.39 in an ex vivo model of squamous
metaplasia induced by air exposure.
In our study, the pathology induced by BAC is not specific
to the limbus and the cornea, as BAC impacts the entire ocular
surface, leading to inflammation and epithelial squamous
metaplasia. Prolonged chronic inflammation may change the
cell fate and lead to the emergence of keratins such as K10, one
of the markers of epithelial squamous metaplasia. However,
based on our results, we supposed that the emergence of
conjunctival K19 and K13 over the cornea probably resulted
from the dysfunction of LSC but not from a cell fate change
with chronic inflammation in the stroma of the cornea. Our
data showed that the K19- and K13-positive epithelium
invaded contiguously into the paracentral cornea with sharp
tips (Figs. 3F, 3L, white arrows). Accordingly, K12 expression
was diminished in the peripheral cornea (Fig. 3T) at 4 weeks
and completely lost in the whole cornea 8 weeks after BAC
termination. These findings indicated that LSCD developed
gradually and that the conjunctivalization progressed from the
limbus toward the central cornea until it fully covered the
cornea (Fig. 8B). If the K19 and K13 were induced by chronic
corneal inflammation through cell fate determination, the
supposition was that they would be first recorded over the
central or paracentral epithelium in a discontiguous pattern
similar to that of K10 (Figs. 3R, 8F).
In conclusion, our findings demonstrated that the ophthal-
mic preservative BAC could induce LSCD in the BALB/c mouse,
with the manifestations including corneal conjunctivalization,
neovascularization, severe inflammation in the corneal stroma
and limbus, and epithelial defect. The phenotypic alterations
included corneal invasion by conjunctiva, emergence of goblet
cells over the cornea, and loss of putative LSC markers. This
novel mouse model of LSCD would be appropriate for detailed
investigation of the mechanisms and evaluation of certain
therapeutic methods in acquired LSCD.
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